Omeros Corporation
OMER
$3.73
Share price
0.27%
Change (1 day)
-24.95%
Change (1 year)
Categories
Omeros Corporation (OMER) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.50 B
According to Omeros Corporation's latest financial reports the company's total liabilities are $0.50 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Omeros Corporation - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.50 B | 27.76% |
| 2021-12-31 | $0.39 B | 31.05% |
| 2020-12-31 | $0.30 B | 22.69% |
| 2019-12-31 | $0.24 B | 25.45% |
| 2018-12-31 | $0.19 B | 64.59% |
| 2017-12-31 | $0.11 B | 13.77% |
| 2016-12-31 | $0.10 B | 39.21% |
| 2015-12-31 | $75.22 M | 40.65% |
| 2014-12-31 | $53.48 M | 53.18% |
| 2013-12-31 | $34.91 M | 5.48% |
| 2012-12-31 | $33.1 M | 1.75% |
| 2011-12-31 | $32.53 M | 28.94% |
| 2010-12-31 | $25.23 M | 33.39% |
| 2009-12-31 | $18.91 M | -83.24% |
| 2008-12-31 | $0.11 B | 16.21% |
| 2007-12-31 | $97.1 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 19,383.14% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 26,962.48% | 🇺🇸 USA |
 Genetic Technologies GENE | $2.49 M | -99.51% | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | $46.89 M | -90.75% | 🇺🇸 USA |